102 related articles for article (PubMed ID: 31631463)
1. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
2. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy.
Williams C; Phillips A; Aggarwal V; Slonim LB; Fajgenbaum DC; Karmali R
Case Rep Oncol; 2021; 14(3):1359-1365. PubMed ID: 34720942
[TBL] [Abstract][Full Text] [Related]
3. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
Takai K
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis for iMCD-TAFRO.
Yoshimi A; Trippett TM; Zhang N; Chen X; Penson AV; Arcila ME; Pichardo J; Baik J; Sigler A; Harada H; Fajgenbaum DC; Dogan A; Abdel-Wahab O; Xiao W
Oncogene; 2020 Apr; 39(15):3218-3225. PubMed ID: 32051554
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.
Rubenstein AI; Pierson SK; Shyamsundar S; Bustamante MS; Gonzalez MV; Milller ID; Brandstadter JD; Mumau MD; Fajgenbaum DC
Br J Haematol; 2024 Mar; 204(3):921-930. PubMed ID: 38168727
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus Treatment for TAFRO Syndrome.
Shirai T; Ichikawa S; Saegusa J
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791031
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival.
Gao YH; Liu YT; Zhang MY; Li SY; Fajgenbaum DC; Zhang L; Li J
Br J Haematol; 2024 May; 204(5):1830-1837. PubMed ID: 38356434
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.
Bustamante MS; Pierson SK; Ren Y; Bagg A; Brandstadter JD; Srkalovic G; Mango N; Alapat D; Lechowicz MJ; Li H; Van Rhee F; Lim MS; Fajgenbaum DC
Haematologica; 2024 Jan; ():. PubMed ID: 38205523
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
10. TAFRO Syndrome on
Jaafari A; Taheri N; Mansour S; El Bouhali SE; Attou R
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786323
[TBL] [Abstract][Full Text] [Related]
11. Radiological Imaging Findings of Adrenal Abnormalities in TAFRO Syndrome: A Systematic Review.
Kurokawa R; Baba A; Kano R; Kaneko Y; Kurokawa M; Gonoi W; Abe O
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672191
[TBL] [Abstract][Full Text] [Related]
12. Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis.
Nishimura Y; Nishimura MF; Fajgenbaum DC; van Rhee F; Sato Y; Otsuka F
EJHaem; 2022 Aug; 3(3):748-753. PubMed ID: 36051051
[TBL] [Abstract][Full Text] [Related]
13. Immunology and targeted therapy in Castleman disease.
Tsunoda S; Harada T; Kikushige Y; Kishimoto T; Yoshizaki K
Expert Rev Clin Immunol; 2024 May; ():1-12. PubMed ID: 38785062
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
[TBL] [Abstract][Full Text] [Related]
15. [Improvement of tissue fibrosis in TAFRO syndrome by prednisolone monotherapy].
Kashiwagi T; Kashiwagi Y; Suzuki T; Shingu M; Kashiwagi S; Hirata T; Hori J; Miyata K; Takechi M; Kishi M; Ohnishi T; Katayama Y; Iwai M; Matsui T
Rinsho Ketsueki; 2024; 65(4):237-242. PubMed ID: 38684433
[TBL] [Abstract][Full Text] [Related]
16. A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction.
Kanda M; Kitamura K; Saito A; Hayashi K; Suzuki T
Cureus; 2024 Apr; 16(4):e58772. PubMed ID: 38779246
[TBL] [Abstract][Full Text] [Related]
17. Unraveling TAFRO Syndrome: An In-Depth Look at the Pathophysiology, Management, and Future Perspectives.
Caballero JC; Conejero N; Solan L; Diaz de la Pinta FJ; Cordoba R; Lopez-Garcia A
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791038
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic Syndrome with Thrombocytopenia, Lymphadenopathy, Systemic Inflammation, and Splenomegaly.
Nakamori A; Akagaki F; Yamaguchi Y; Arima R; Sugiura T
Intern Med; 2018 Apr; 57(8):1123-1129. PubMed ID: 29269660
[TBL] [Abstract][Full Text] [Related]
19. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Zhang L; Dong YJ; Peng HL; Li H; Zhang MZ; Wang HH; Liu QH; Su LP; Zhong LY; Wu WJ; Huang L; Yan XJ; Fan L; Tang WJ; Li ZL; Bi LT; Li Y; Gao GX; Gao L; Liu TB; Wei YQ; Liu Y; Yu L; Zhou H; Sun CY; Qian WB; Zou DH; Zhang HL; Ding KY; Wang XB; Bai O; Huang WR; Chen B; Yang L; Song J; Gao D; Chen T; Luo J; Wang SY; Ma LM; Fajgenbaum DC; Li J;
Lancet Reg Health West Pac; 2023 May; 34():100720. PubMed ID: 37283978
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.
Oka S; Ono K; Nohgawa M
Clin Case Rep; 2018 Apr; 6(4):644-650. PubMed ID: 29636932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
